Press Releases

Featured Press Releases

BIO Applauds Introduction of Bipartisan…

BIO President and CEO John F. Crowley today released the following statement after a bipartisan group of Senators, Sen. Bob Casey (D-PA), Sen. Markwayne Mullin (R-OK), Sen. Sherrod Brown (D-OH), and Sen. Susan Collins (R-ME), introduced the Creating…

Learn more

BIO International Convention Celebrates Another…

Biotechnology Innovation Organization (BIO) is proud to conclude the 2024 BIO International Convention in San Diego, held last week June 3-6, 2024. 1,400 exhibitors and more than 19,500 attendees from 70 countries came together for four full days of…

Learn more

BIO Recognizes Industry Leaders for…

WASHINGTON - June 5, 2024 – The Biotechnology Innovation Organization (BIO) today announced the winners of the organization’s 2024 Leadership in Agri-Biotechnology Awards — honoring Dr. Annette Kleiser, CEO of Dalan Animal Health, as the recipient…

Learn more

BIO Applauds Senate Passage of the 21st Century Cures Act

December 7, 2016

Washington, DC (December 7, 2016) – Biotechnology Innovation Organization (BIO) President and CEO James C. Greenwood issued the following statement today regarding passage of the 21st Century Cures Act by the U.S. Senate:

BIO Applauds House Passage of the 21st Century Cures Act

November 30, 2016

Washington, DC (November 30, 2016) – Biotechnology Innovation Organization (BIO) President and CEO James C. Greenwood issued the following statement today regarding passage of the 21st Century Cures Act by the U.S. House of Representatives:

BIO Responds to GAO Report Declaring RFS Will Not Meet Goals

November 29, 2016

BIO responds to GAO's latest report on the Renewable Fuel Standard (RFS), “Renewable Fuel Standard, Program Unlikely to Meet its Targets for Reducing Greenhouse Gas Emissions.” GAO correctly concludes the technology is available for advance biofuels…

BIO Welcomes EPA’s Final 2017 Renewable Fuel Standards

November 23, 2016

The Environmental Protection Agency’s final Renewable Fuel Standards for 2017 and biomass-based diesel volume for 2018 appear to put the program back on track and will provide considerable additional certainty for investors in advanced and…

BIO Statement on FDA Product Communications Hearing

November 9, 2016

BIO President and CEO Jim Greenwood released the following statement today regarding the FDA’s hearing on product communications:“In the era of data-driven medicine, where all parties seek more, not less, information about the safety,…

BIO Patient and Health Advocacy Summit Hosts Over 300 Attendees from Wide Range of Health Care Organizations

November 4, 2016

Over 200 diverse groups were represented at the November 3-4 meeting in Washington, D.C.

BIO Issues Call for Papers for 2017 World Congress on Industrial Biotechnology in Montréal

November 1, 2016

BIO has officially issued a call to leaders from the biotechnology, bioenergy, chemical, consumer products manufacturing, and agricultural industries as well as academia and financial sectors industries to submit panel session proposals for the…

BIO Asks Congress to Extend Critical Bioenergy Tax Credits During Lame-Duck

October 18, 2016

BIO today sent a letter to Congressional Leadership, the Senate Finance Committee Chairs, and the House Ways and Means Committee Chairs calling for the extension of renewable energy tax credits slated to expire at the end of 2016. In its letter…

BIO Names Dana O’Brien Executive Vice President for Food & Agriculture Section

October 13, 2016

BIO announced today that Dana O’Brien has been named BIO’s Executive Vice President for its Food & Agriculture Section.

New BIO Report Dispels the Myth of the Blend Wall and High RIN Prices

October 4, 2016

Data recently released by EPA on compliance with the Renewable Fuel Standard between 2010 and 2013 (the latest year for which compliance is complete) challenges the widely accepted assumption that the blend wall – the point at which ethanol blending…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.